# Topical Timolol for Superficial Infantile Hemangioma

> **NCT01685398** · PHASE3 · COMPLETED · sponsor: **Mahidol University** · enrollment: 48 (actual)

## Conditions studied

- Hemangioma

## Interventions

- **DRUG:** 0.5% timolol maleate eye drop
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT01685398
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2023-03
- **Final completion:** 2023-03
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01685398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01685398, "Topical Timolol for Superficial Infantile Hemangioma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01685398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*